The Supreme Court ruled Thursday morning that breast cancer gene patents controlled by a Salt Lake City company, Myriad Genetics, are invalid. KCPW Reporter Kim Schuske has this story.
Isolated Genes Cannot Be Patented Says the Supreme Court
Additional Programming Provided by
